{"id":"https://openalex.org/W4362395825","doi":"https://doi.org/10.1158/1078-0432.22455749","title":"Supplementary Figure 2 from The Anti-CD19 Antibody\u2013Drug Conjugate SAR3419 Prevents Hematolymphoid Relapse Postinduction Therapy in Preclinical Models of Pediatric Acute Lymphoblastic Leukemia","display_name":"Supplementary Figure 2 from The Anti-CD19 Antibody\u2013Drug Conjugate SAR3419 Prevents Hematolymphoid Relapse Postinduction Therapy in Preclinical Models of Pediatric Acute Lymphoblastic Leukemia","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4362395825","doi":"https://doi.org/10.1158/1078-0432.22455749"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22455749","doi":"https://doi.org/10.1158/1078-0432.22455749","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22455749","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_The_Anti-CD19_Antibody_Drug_Conjugate_SAR3419_Prevents_Hematolymphoid_Relapse_Postinduction_Therapy_in_Preclinical_Models_of_Pediatric_Acute_Lymphoblastic_Leukemia/22455749/1/files/39906893.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_The_Anti-CD19_Antibody_Drug_Conjugate_SAR3419_Prevents_Hematolymphoid_Relapse_Postinduction_Therapy_in_Preclinical_Models_of_Pediatric_Acute_Lymphoblastic_Leukemia/22455749/1/files/39906893.pdf","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110170888","display_name":"Hern\u00e1n Carol","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hernan Carol","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089263244","display_name":"Barbara Szymanska","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Barbara Szymanska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037060417","display_name":"Kathryn Louise Evans","orcid":"https://orcid.org/0000-0002-7884-5877","observed_orcids":["https://orcid.org/0000-0002-7884-5877"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kathryn Evans","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111519545","display_name":"Ingrid Boehm","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ingrid Boehm","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109173471","display_name":"Peter J. Houghton","orcid":"https://orcid.org/0000-0002-2400-8184","observed_orcids":["https://orcid.org/0000-0002-2400-8184"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter J. Houghton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046943976","display_name":"Malcolm Anders Smith","orcid":"https://orcid.org/0000-0001-9880-9876","observed_orcids":["https://orcid.org/0000-0001-9880-9876"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Malcolm A. Smith","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5028049853","display_name":"Richard B. Lock","orcid":"https://orcid.org/0000-0002-3436-9071","observed_orcids":["https://orcid.org/0000-0002-3436-9071"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard B. Lock","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9272000193595886,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9272000193595886,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.06650000065565109,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/childhood-acute-lymphoblastic-leukemia","display_name":"childhood acute lymphoblastic leukemia","score":0.9769999980926514},{"id":"https://openalex.org/keywords/b-cell-precursor-acute-lymphoblastic-leukemia","display_name":"B-cell precursor acute lymphoblastic leukemia","score":0.8700000047683716},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.746999979019165},{"id":"https://openalex.org/keywords/event-free-survival","display_name":"event-free survival","score":0.656000018119812},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.656000018119812},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.3140000104904175}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5833278298377991},{"id":"https://openalex.org/C2993640289","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Solid tumor","level":3,"score":0.5454687476158142},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.46299654245376587},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.43916404247283936},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.4329041838645935},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3809458315372467},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34908339381217957},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.24755674600601196},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17280671000480652},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.13351374864578247},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.12188705801963806},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.22455749","doi":"https://doi.org/10.1158/1078-0432.22455749","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22455749","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_The_Anti-CD19_Antibody_Drug_Conjugate_SAR3419_Prevents_Hematolymphoid_Relapse_Postinduction_Therapy_in_Preclinical_Models_of_Pediatric_Acute_Lymphoblastic_Leukemia/22455749/1/files/39906893.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22455749","doi":"https://doi.org/10.1158/1078-0432.22455749","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22455749","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_The_Anti-CD19_Antibody_Drug_Conjugate_SAR3419_Prevents_Hematolymphoid_Relapse_Postinduction_Therapy_in_Preclinical_Models_of_Pediatric_Acute_Lymphoblastic_Leukemia/22455749/1/files/39906893.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W4362395825.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2112083044","https://openalex.org/W4361951290","https://openalex.org/W4244614226","https://openalex.org/W2169000897","https://openalex.org/W2583926568","https://openalex.org/W2560281006","https://openalex.org/W2165800290","https://openalex.org/W196094705","https://openalex.org/W53326808","https://openalex.org/W2576915975"],"abstract_inverted_index":{"PDF":[0],"file":[1],"-":[2],"2999K,":[3],"SAR3419":[4,31,77],"is":[5],"effective":[6],"against":[7],"BCP-ALL":[8],"xenografts":[9],"in":[10,105],"vivo":[11],"over":[12],"a":[13],"broad":[14],"dose":[15],"range.":[16],"Mice":[17],"engrafted":[18,64],"with":[19,24,54,65,70],"ALL-4":[20],"(A)":[21],"were":[22,68],"treated":[23,69],"vehicle":[25,71],"control":[26,72],"(dotted":[27,73],"black":[28,74],"line),":[29,37,42,47,75],"or":[30,53,76],"at":[32,78,85],"10":[33,79],"mg/kg":[34,39,44,49,80,87],"(solid":[35,40,45,50,81,88],"red":[36,82],"7.5":[38],"green":[41],"5":[43],"blue":[46,89],"2.5":[48],"orange":[51],"line)":[52,61,83],"the":[55,100,106],"unconjugated":[56],"MAb":[57],"huB4":[58],"(gray":[59],"dotted":[60],"while":[62],"mice":[63,110],"ALL-19":[66],"(B)":[67],"and":[84,113],"1.0":[86],"line).":[90],"Response":[91],"to":[92],"treatment":[93,123],"was":[94],"monitored":[95],"by":[96],"weekly":[97],"enumeration":[98],"of":[99,102,108,116],"proportion":[101],"%huCD45+":[103],"cells":[104],"PB":[107],"individual":[109],"(left":[111],"panels),":[112],"Kaplan-Meier":[114],"analysis":[115],"EFS":[117],"(right":[118],"panels).":[119],"Gray":[120],"arrows":[121],"indicate":[122],"time":[124],"points.":[125]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2023-04-05T00:00:00"}